The paradox of hyperdopaminuria in aromatic l-amino acid deficiency explained

JIMD Reports

Volumn 4, Issue , 2012, Pages 39-45

  Wassenberg, Tessa ^a   Monnens, Leo A H ^a   Geurtz, Ben P B H ^a   Wevers, Ron A ^a   Verbeek, Marcel M ^a   Willemsen, Michèl A A P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dopamine production; Neurometabolic disorder; Sodium homeostasis; Substrate availability; Urine production

Indexed keywords

EID: 85009733268     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2011_84     Document Type: Chapter

References (24)

1. Abeling NG, Brautigam C, Hoffman GF et al (2000) Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency. J Inherit Metab Dis 23:325–328
2. Aperia AC (2000) Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62:621–647
3. Barhelmebs M, Mbou P, Stephan D, Grima M, Imbs JL (1993) Renal dopamine excretion in healthy volunteers after oral ingestion of L-dopa. Fundam Clin Pharmacol 7:11–16
4. Baines AD, Drangova R, Hatcher C (1980) Dopamine production in isolated glomeruli and tubules from rat kidney. Can J Physiol Pharmacol 63:155–158
5. Brun L, Ngu LH, Keng WT et al (2010) Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology 75:64–71
6. Chan YL (1976) Cellular mechanisms of renal tubular transport of L-dopa and its derivates in the rat: microperfusion studies. J Pharmacol Exp Ther 199:17–24
7. Chen L, Zhuang X (2003) Transgenic mouse models of dopamine deficiency. Ann Neurol 54(Suppl 6):S91–102
8. Eisenhofer G, Aneman A, Friberg P et al (1997) Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864–3871
9. Fiumara A, Brautigam C, Hyland K et al (2002) Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies. Neuropediatrics 33:203–208
10. Goldstein DS, Eisenhofer G, Kopin IJ (2003) Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800–811
11. Ibarra FR, Armando I, Nowicki S et al (2005) Dopamine is metabolised by different enzymes along the rat nephron. Pflugers Arch 450:185–191
12. Moreira-Rodrigues M, Sampaio-Maia B, Pestana M (2009) Renal dopaminergic system activity in rat remnant kidney up to twenty-six weeks after surgery. Life Sci 27:409–414
13. Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P (2001) Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 16(Suppl 1):53–59
14. Quinones H, Collazo R, Moe OW (2004) The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol 287:F74–80
15. Sampaio-Maia B, Serrao P, Vieira-Coelho MA, Pestana M (2003) Differences in the renal dopaminergic system activity between Wistar rats from two suppliers. Acta Physiol Scand 178:83–89
16. Sampaio-Maia B, Moreira-Rodrigues M, Pestana M (2006) Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney. Nephron Physiol 103:14–24
17. Soares-da-Silva P, Fernandes MH (1990) Synthesis and metabolism of dopamine in the kidney. Am J Hypertension 3:7S–10S
18. Soares-da-Silva P, Vieira-Coelho MA, Serrao MP (1997) Uptake of L-3,4-dihydroxyphenylalanine and dopamine formation in cultured renal epithelial cells. Biochem Pharmacol 54:1037–1046
19. Soares-da-Silva P, Pestana M, Ferreira A, Damasceno A, Polonia J, Cerqueira-Gomes M (2000) Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure. Clin Exp Hypertens 22:251–268
20. Verbeek MM, Geurtz PB, Willemsen MA, Wevers RA (2007) Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes. Mol Genet Metab 90:363–369
21. Vieira-Coelho MA, Soares-da-Silva P (1998) Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-2. Am J Physiol 275:C104–112
22. Wang Y, Berndt TJ, Gross JM, Peterson MA, So MJ, Knox FG (2001) Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function. Am J Physiol Regul Integr Comp Physiol 280:R248–54
23. Wassenberg T, Willemsen MA, Geurtz PB et al (2010) Urinary dopamine in aromatic L-amino acid decarboxylase deficiency: the unsolved paradox. Mol Genet Metab 101:349–356
24. Willemsen MA, Verbeek MM, Kamsteeg EJ et al (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catechol-amine biosynthesis. Brain 133:1810–1822